Pill could delay diabetes in prediabetics study says
A Lancet report shows starch blocker acarbose reduced progression to diabetes by 25 percent in 1400 prediabetic adults across nine countries. The drug slows sugar breakdown, but side effects limit use. Bayer funded the trial.
MENTIONED IN THIS ARTICLE
London
Lancet Medical Journal
Bayer
Eye drops may slow glaucoma in ocular hypertension
A study of 1636 adults with ocular hypertension shows daily eye drops reduced progression to glaucoma within five years from 9.5 percent to 4.4 percent. Co author Dr. James Brandt of UC Davis says proven therapies can preserve sight. findings published in Archives of Ophthalmology with NEI funding.
MENTIONED IN THIS ARTICLE
Chicago
U.S
James Brandt
University of California At Davis
Archives of Ophthalmology
National Eye Institute
Panel backs broader hepatitis C therapy access
A federal advisory panel advises not to exclude drug users children and AIDS patients from hepatitis C treatment. The 12 member NIH selected panel notes improved therapy and urges expanding access amid about 4 million infected Americans, with transmission via shared needles high risk sex and organ transplant.
MENTIONED IN THIS ARTICLE
Washington
National Institutes of Health
Americans
America
Also Mentioned on This Page
United States
Europe
Edwin Gale
University of Bristol
England
Sprint
Sprint Pcs
PCS
E. Main St
Cube Phones
My Wireless
Sprint Spectrum LP
Diamond
Sprint Communications Company LP